The National Institute for Health and Care Excellence (NICE), has published final draft guidance recommending dupilumab as a treatment option for eligible adults with uncontrolled chronic obstructive ...
This publication aims to improve treatment and care for adults with chronic obstructive pulmonary disease (COPD). It provides commissioners with strategies and recommendations for frontline care, ...
Almost 30,000 people in England with a respiratory disease called COPD (chronic obstructive pulmonary disease) could have their lives transformed after NICE today recommended a new targeted treatment ...
The primary finding from the clinical trials for the COPD biologics is reduced annual exacerbations by 30% (BOREAS trial) and 34% (NOTUS trial). In the BOREAS trial, in addition to reduced ...
Chronic obstructive pulmonary disease (COPD) remains a substantial contributor to morbidity and mortality in the United States with an estimated 3.8% age-adjusted prevalence and 141,733 COPD deaths ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results